InSysBio to participate in Biomarkers for Alzheimer’s Disease Summit

events
Conference
August 6, 2021

August 6, 2021

InSysBio will take part in Annual Biomarkers for Alzheimer’s Disease Summit, Digital Event which is going to be held August 24-26, 2021. InSysBio will present its Neurodegeneration modeling issues and Alzheimer’s Disease Platform update at its Virtual Booth!
Moreover, Tatiana Karelina, Head of Neurodegenerative Diseases Modeling Team, will give a talk on the topic “Mechanistic modeling approach to prediction and analysis of clinical trial results in neurodegeneration area”.

Tatiana is going to shed the light on the following points:

  • Quantitative system pharmacology (QSP) modeling of clinical trials facilitates interpretation of information provided by biomarkers.
  • QSP methods allows for investigation of interaction between pathological mechanisms, biomarkers and treatment: example for aducanumab clinical trial.
  • Combinatorial therapy efficacy on endpoints, intrinsic mechanisms and biomarkers can be potentially predicted by QSP.

10:35 EDT | 07:35 PDT on Wednesday, August 25.

Visit our Virtual Booth and follow our speaker!

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 120 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

February 2020
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
1. 19 Feb 2020 12:54 InSysBio to participate in ASCPT 2020 InSysBio announced its participation in 121st Annual meeting of American Society for Clinical Pharmacology and Therapeutics (ASCPT 2020) which is to be held on March 18-21, 2020 at Marriott Marquis Houston, TX. InSysBio welcomes visitors at the booth # 102. Oleg Demin, CEO of InSysBio, Tatiana Karelina, lead modeler in Alzheimer's Disease and Veronika Musatova, Head of IRT development team, will present the new version of IRT (Immune Response Template) and Cytocon DB (Cell and cYTOkine CONcentrations).
20
21
1. 21 Feb 2020 17:02 InSysBio presents an enhanced version of its Immune Response Template Database IRT Version 3.0.0 acquires a wide variety of updates and new options (Moscow – 21.02.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, moves forward to the future.
22
23
24
25
26
27
28
29
 
Upcoming Events
Tags
Latest News
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha